← Evidence map

ArticleThe British journal of dermatology2022

Another anti-interleukin (IL)-17 inhibitor: is there an advantage of blocking IL-17A and IL-17F?

Sascha Gerdes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 35377958